483 Michael W Konstan MD Feb 2015

483 Michael W Konstan MD Feb 2015

Janet Bowen FDA$119.00 - Available Now

FDA investigators audited the Michael W Konstan MD - Cleveland, OH, United States facility and issued 1 inspectional observation (via FDA 483) on 13 Feb 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 13 Feb 2015
  • Location: Cleveland, United States
  • FEI: 3004358077
Add To Cart